fentanyl · Medicine question

What risk to newborns has been reported with chronic use of Durogesic DTrans fentanyl patches during pregnancy?

Name: What risk to newborns has been reported with chronic use of Durogesic DTrans fentanyl patches during pregnancy?
Published: 2026-11-08T13:47:02.558Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Neonatal withdrawal syndrome has been reported in newborn infants following chronic maternal use of Durogesic DTrans fentanyl patches during pregnancy.

Sources for this answer

Durogesic DTrans 12 mcg/hr Transdermal PatchJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 50Document updated 18 September 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about fentanyl